Insider · CIK 0002094828
Stefan Lutz
officer
Files at CDXS (CODEXIS, INC.). First filing Jan 8, 2026, latest Feb 25, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $18k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CDXS: CODEXIS, INC.
CDXSOct 9, 2026 · close 1.41
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | CDXSsell CODEXIS, INC. | $6,641 5,862 shares | -4% | +4% from low-73% from high | |
| 30Weak | CODEXIS, INC. | $3,257 2,492 shares | -2% | +7% from low-70% from high | |
| 15Weak | CDXSsell CODEXIS, INC. | $7,950 4,685 shares | -3% | +10% from low-66% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | CDXS CODEXIS, INC. | SOpen-market sale Common Stock | -5,862 | $1.13 | $6,641 | 130,421 | Feb 25, 2026 |
| Feb 23, 2026 | CDXS CODEXIS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +316,100 | $0.00 | $0 | 316,100 | Feb 25, 2026 |
| Feb 6, 2026 | CDXS CODEXIS, INC. | SOpen-market sale Common Stock | -2,492 | $1.31 | $3,257 | 136,283 | Feb 9, 2026 |
| Jan 7, 2026 | CDXS CODEXIS, INC. | SOpen-market sale Common Stock | -4,685 | $1.70 | $7,950 | 138,775 | Jan 8, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.